Skip to content
Stop using now Drug recall · FDA · Published January 10, 2014

Hospira Dobutamine Recall: Glass Particulate Hazard

Hospira recalls 123,900 vials of Dobutamine Injection due to glass particulate. Check lot 27-352-DK and expiration 03/15.

🇺🇸 FDA recall #D-1540-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.375 N Field Dr · Lake Forest, IL 60045-2513
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 123,900 vials of Dobutamine Injection, USP (250 mg per 20 mL) due to the presence of particulate matter. The hazard involves a chip in the glass neck of the vial that can cause solution discoloration and release glass particles into the medication. This recall affects units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/46321-hospira-inc-recalls-dobutamine-injection-usp-250-mg-per-20.

Source Summary by GovInfoNow · govinfonow.com/recall/46321-hospira-inc-recalls-dobutamine-injection-usp-250-mg-per-20 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1540-2014

Cite this page

“Hospira Dobutamine Recall: Glass Particulate Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46321-hospira-inc-recalls-dobutamine-injection-usp-250-mg-per-20. Based on FDA recall #D-1540-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1540-2014%22&limit=1).

The FDA announced on Jan. 10, 2014, that Hospira Inc. voluntarily recalled DOBUTamine Injection vials due to glass particulate matter in the solution. Owners should return the product for a refund.

How to tell if you have it

  • Brand: Hospira
  • Product: DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial
  • NDC: 0409-2344-02
  • Lot #: 27-352-DK
  • Expiration: 03/15
  • Quantity: 123,900 vials

The hazard

The recall addresses the presence of particulate matter, specifically a discolored solution caused by a chip in the glass at the neck of the vial and glass particulate found within the solution.

Context

GovInfoNow's records show Hospira Inc. has had 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026), American Regent Papaverine HCl Injection (July 24, 2026), and Fresenius Kabi Tyenne Injection (Aug. 10, 2026).

How to tell if you have this one

Check for Dobutamine Injection, USP, 250 mg per 20 mL in 20 mL Single-dose Fliptop Vials manufactured by Hospira Inc. Look specifically for NDC 0409-2344-02 and Lot # 27-352-DK with an expiration date of 03/15.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Affected Vials

    Do not administer any vials matching the recalled lot number or NDC to patients.

  2. Inspect Inventory

    Check all stock for NDC 0409-2344-02 and Lot # 27-352-DK with expiration 03/15.

  3. Contact Manufacturer

    Reach out to Hospira Inc. for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: Jan 10, 201412. FDA classified it Class I: Aug 18, 201423. Published in FDA’s Enforcement Report: Aug 27, 201434. FDA terminated the recall: Jul 14, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1540-2014 (January 10, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1540-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA